- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 239/14 - Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
Patent holdings for IPC class C07C 239/14
Total number of patents in this class: 17
10-year publication summary
|
0
|
2
|
0
|
2
|
0
|
0
|
2
|
0
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Lantern Pharma Inc. | 94 |
4 |
| Generics [UK] Limited | 106 |
2 |
| Versitech Limited | 282 |
2 |
| Pfizer Inc. | 3422 |
1 |
| AF Chemicals | 1 |
1 |
| The Chinese University of Hong Kong | 771 |
1 |
| Institute of Genetics and Developmental Biology, Chinese Academy of Sciences | 188 |
1 |
| Oxford University Innovation Limited | 1686 |
1 |
| Peking University | 1481 |
1 |
| Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences | 69 |
1 |
| LEO Pharma A/S | 447 |
1 |
| Dispoltec B.V. | 5 |
1 |
| Other owners | 0 |